Unjha Formulations Ltd. benchmarking: Perfomance to industry peers

Financial

	Unjha Formulations	Parmax Pharma	Senbo Industries
Operational Metrics
Financials
5 yr Average ROE	10.34 %	24.13 %	n/a
5yr average Equity Multiplier	1.62	29.23	n/a
5yr Average Asset Turnover Ratio	3.51	1.05	n/a
5yr Avg Net Profit Margin	1.88 %	-11.29 %	n/a
Price to Book	2.07	0.0	n/a
P/E	9.03	0.0	n/a
5yr Avg Cash Conversion Cycle	18.8 Days	-92.25 Days	n/a
Inventory Days	28.57 Days	69.37 Days	n/a
Days Receivable	41.04 Days	20.01 Days	n/a
Days Payable	53.92 Days	296.94 Days	n/a
5yr Average Interest Coverage Ratio	17.56	-0.77	n/a
5yr Avg ROCE	19.44 %	-14.3 %	n/a
5yr Avg Operating Profit Margin	3.19 %	2.43 %	n/a
5 yr average Debt to Equity	0.0	10.96	n/a
5yr CAGR Net Profit	32.6 %	n/a	n/a
5yr Average Return on Assets	6.62 %	-9.05 %	n/a
Shareholdings
Promoter Holding	36.92 %	30.8 %	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	0.0	0.0	n/a
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	n/a